Albers Jeffrey W. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
66
Insider Sells Sum
$81.8M

Insider Activity of Albers Jeffrey W.

According to the SEC Form 4 filings, Albers Jeffrey W., being in a position of

  1. director at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5000 shares for $448,823,
    over all time since 2024-01-23, has bought 0 shares, and sold 36349 shares for $1.8M.

Biography of Albers Jeffrey W.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,853,0132100

Comparison of Insiders on Amount of Buys and Sells

2026-08-07SaleSpyre Therapeutics, Inc.
SYRE
director
23,000
0.027%
$104.53$2.4M-13.31%
2025-12-08SaleKymera Therapeutics, Inc.
KYMR
director
5,000
0.0066%
$89.76$448,823-7.32%
2025-10-13SaleKymera Therapeutics, Inc.
KYMR
director
5,000
0.0069%
$59.19$295,949+41.31%
2025-06-03SaleKymera Therapeutics, Inc.
KYMR
director
6,349
0.011%
$49.00$311,101+52.87%
2024-11-06SaleSpyre Therapeutics, Inc.
SYRE
director
6,700
0.0148%
$36.76$246,313-53.75%
2024-10-25SaleSpyre Therapeutics, Inc.
SYRE
director
300
0.0007%
$36.43$10,929-50.33%
2024-08-26SaleKymera Therapeutics, Inc.
KYMR
director
5,000
0.0077%
$49.10$245,509-13.77%
2024-02-21SaleKymera Therapeutics, Inc.
KYMR
director
4,385
0.0075%
$39.05$171,227+8.22%
2024-02-20SaleKymera Therapeutics, Inc.
KYMR
director
615
0.0011%
$39.07$24,031+10.04%
2024-01-23SaleKymera Therapeutics, Inc.
KYMR
director
10,000
0.0163%
$30.05$300,470+33.8%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.